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Abstract
Little is known about excessive daytime sleepiness (EDS) in heart failure (HF). The aim of this cross-sectional
descriptive study was to describe the prevalence of EDS and factors associated with it in HF. A secondary
purpose was to explore the correlates of fatigue. We enrolled a consecutive sample of 280 adults with a
confirmed diagnosis of chronic HF from three outpatient settings in the northeastern United States. Patients
with major depressive illness were excluded. Clinical, sociodemographic, behavioral, and perceptual factors
were explored as possible correlates of EDS. Using an Epworth Sleepiness Scale score > 10, the prevalence of
EDS was 23.6%. Significant determinants of EDS were worse sleep quality (p = .048), worse functional class
(p = .004), not taking a diuretic (p = .005), and lack of physical activity (p = .04). Only sleep quality was
associated with fatigue (p < .001). Sleep-disordered breathing was not significantly associated with EDS or
with fatigue. These factors may be amenable to intervention.
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Abstract
Little is known about excessive daytime sleepiness (EDS) in heart failure (HF). The aim of this
cross-sectional descriptive study was to describe the prevalence of EDS and factors associated
with it in HF. A secondary purpose was to explore the correlates of fatigue. We enrolled a
consecutive sample of 280 adults with a confirmed diagnosis of chronic HF from three outpatient
settings in the northeastern US. Patients with major depressive illness were excluded. Clinical,
sociodemographic, behavioral, and perceptual factors were explored as possible correlates of EDS.
Using an Epworth Sleepiness Scale score >10, the prevalence of EDS was 23.6%. Significant
determinants of EDS were worse sleep quality (p=0.048), worse functional class (p=0.004), not
taking a diuretic (p=0.005), and lack of physical activity (p=0.04). Only sleep quality was
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associated with fatigue (p<0.001). Sleep disordered breathing was not significantly associated with
EDS or with fatigue. These factors may be amenable to intervention.
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Determinants of Excessive Daytime Sleepiness and Fatigue in Adults with
Heart Failure
Heart failure (HF) affects almost 6 million Americans (2.4% of the population) (Roger et al.,
2011) and as many as 70% of these patients report poor sleep (Jaarsma et al., 1999). Adults
with HF have more frequent wake bouts, poorer overall sleep quality, and more excessive
daytime sleepiness (EDS) than adults without HF (Redeker & Stein, 2006). EDS can be
disabling, reducing waking performance, (Philip et al., 2008) increasing psychosocial stress,
(Redeker, 2006) and decreasing quality of life (Skobel et al., 2005).
What This Study is About
This study is about EDS and fatigue in adults with HF. This is an area of research that is
new in HF and the correlates of EDS are unknown in these patients. Fatigue is very common
in HF and patients have difficulty discriminating between EDS and fatigue. So, we also
explored the prevalence and correlates of fatigue as well.
What is Known about Excessive Daytime Sleepiness
EDS refers to difficulty maintaining a desired level of wakefulness with a feeling of being
drowsy during wakeful states (Ohayon, 2008; Young, 2004). The prevalence of EDS in
adults with HF is unclear. In the general population EDS has been reported in 8%
(Johansson et al., 2010) to 20% of samples (Whitney et al., 1998). In adults with HF, there is
considerable overlap with the general population, with rates between 15% and 44% reported
(Brostrom, Stromberg, Dahlstrom, & Fridlund, 2004; Javaheri et al., 1998; Johansson,
Alehagen, Svanborg, Dahlstrom, & Brostrom, 2009; Johansson, et al., 2010; Redeker &
Stein, 2006; Staniforth, Kinnear, Starling, & Cowley, 1998).
The factors associated with EDS in adults with HF have not been explored previously.
Correlates of EDS have been explored in other populations with mixed results. For example,
in the Cardiovascular Health Study of 4578 Medicare enrollees in the US, factors associated
with EDS were non-white race, depression, loud snoring, awakening with dyspnea or
snorting, frequent nocturnal awakenings, HF medications, non-use of sleeping pills, a
sedentary lifestyle, and limitation of activities of daily living (Whitney, et al., 1998). In a
population-based sample of middle-aged (mean 47±8 years) adults (n=2913), EDS was
related to gender (females), age (younger), and higher sleep debt (Kim & Young, 2005). A
consistent finding across several of studies is that EDS is not associated with sleep
disordered breathing (SDB) in adults with HF (Michael Arzt et al., 2006; Ferreira et al.,
2010; Johansson, Alehagen, Svanborg, Dahlstrom, & Brostrom, 2009; Kaneko et al., 2003;
Redeker, Muench, et al., 2010). But, in a sample of 293 older adults without HF (mean 78
years, range 65–98 years) EDS was associated with gender (males), severe sleep-disordered
breathing (SDB), poor sleep quality, increased percentage of time in rapid eye movement
sleep, frequent pain at night, wheezing or whistling from chest at night, and daytime
medications with sleepiness as a side effect (Pack et al., 2006). Alcohol use reduced the risk
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of EDS. The only consistent factor among these samples was poor sleep quality. These
mixed findings highlight the need for further study of EDS in adults with HF.
Since the prevalence of EDS in adults with HF is still in question and the correlates of EDS
are unknown in adults with HF, the primary purpose of this study was to describe the
prevalence of EDS and the factors associated with it in this population. Specifically, we
sought to identify contributors to EDS in HF patients that may be reversible and potentially
amenable to intervention.
A secondary purpose was to explore the prevalence and correlates of fatigue because
patients have difficulty differentiating between EDS and fatigue (Hossain et al., 2005;
Singareddy, Bixler, & Vgontzas, 2010). Both symptoms are cardinal indicators of cytokine-
induced sickness behavior, which is now recognized as an important contributor to the HF
symptom experience (Dantzer & Kelley, 2007). In response to an infection, physiological
concentrations of proinflammatory cytokines act in the brain to produce the common
symptoms of sickness, such as loss of appetite, sleepiness, withdrawal from normal social
activities, fever, aching joints and fatigue. Cytokines may produce these same symptoms in
HF. Few investigators have studied both EDS and fatigue in HF patients and the one team
that did so demonstrated that EDS and fatigue were not highly correlated (Redeker, Jeon, et
al., 2010). Therefore, after identifying the factors associated with EDS we tested the same
model using fatigue as the outcome to determine if the factors explaining EDS also
explained fatigue.
Methods
This was a planned analysis of cross-sectional data from a study enrolling a consecutive
sample of 280 adults with HF. Subjects were enrolled from three outpatient settings in
Philadelphia, Pennsylvania and Newark, Delaware. One site was a university referral center,
one site was a large community hospital, and one was a Veterans Affairs medical center.
The local Institutional Review Board approved the study at each site. All participants
provided informed consent. These data were collected between 2007 and 2009.
Patients were included if they had chronic Stage C HF confirmed based on recent
echocardiographic and clinical evidence. Stage C HF patients are currently or previously
symptomatic. Patients with either systolic or preserved left ventricular systolic function
(diastolic HF) were included. Systolic dysfunction was defined as having a left ventricular
ejection fraction ≤ 40%. Diastolic HF was confirmed based on clinical symptoms in addition
to echocardiographic findings of an ejection fraction >40% and a reversed mitral inflow E/A
ratio plus exclusion of alternative diagnoses (i.e., ischemia, valvular disease, occult
arrhythmia, pericardial disease, restrictive cardiomyopathy, lung disease) (Hunt et al., 2005).
Inclusion criteria specified the ability to perform tests (e.g., vision, hearing, and English
literacy). The cognitive ability to provide informed consent was screened using the
Telephone Interview of Cognitive Status (Buckwalter, Crooks, & Petitti, 2002). Otherwise
eligible individuals were excluded if they lived in a long term care setting or worked nights
or rotating shifts, or had a major depressive illness, dementia, renal failure requiring dialysis,
a life expectancy of less than 6 months, plans to move out of the area, or a history of serious
drug or alcohol abuse within the past year at the time of screening (Cherpitel, 2000). Major
depressive illness was screened first by a review of the medical record; patients identified as
having major depressive illness were not contacted. In addition, everyone was screened with
the 9-item Patient Health Questionnaire (PHQ-9) (Kroenke, Spitzer, & Williams, 2001). We
excluded anyone reporting 5 or more of the 9 symptoms more than half the days in the past
2 weeks; 1 of the symptoms had to be depressed mood or anhedonia. Most of the data were
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collected during home visits by trained research assistants. Clinical information was
abstracted from the medical record by registered nurses.
Measurement
Using information collected at enrollment, we tested a model of sociodemographic, clinical,
behavioral, and perceptual factors suggested by others to be associated with EDS in other
populations. We explored sociodemographic characteristics of age (Kim & Young, 2005;
Whitney, et al., 1998), race (Whitney, et al., 1998), gender (Kim & Young, 2005; Pack, et
al., 2006; Teodorescu et al., 2006), education (Kim & Young, 2005; Whitney, et al., 1998),
income (Ekici et al., 2008), and social support (Whitney, et al., 1998). Clinical factors tested
were SDB (Pack, et al., 2006), number of comorbid illnesses (Katz & McHorney, 1998;
Pack, et al., 2006; Whitney, et al., 1998), blood pressure (Drager et al., 2009), body mass
index (BMI) (Guilleminault et al., 1988; Whitney, et al., 1998), HF type, severity
(Staniforth, et al., 1998), and duration (Whitney, et al., 1998), number and type of
medications (Whitney, et al., 1998), including drugs known to cause daytime somnolence
(Pack, et al., 2006), and diuretics, which may cause nocturia (Asplund, 2004; Foley et al.,
2007). Behavioral and perceptual factors included exercise (Whitney, et al., 1998), alcohol
use (Pack, et al., 2006; Whitney, et al., 1998), smoking (Whitney, et al., 1998), sleep
duration and quality (Redeker & Stein, 2006), and perceived health (Enright et al., 1996).
Depression was not included as a potential correlate because subjects with major depression
were excluded and because of the conceptual overlap between EDS, fatigue, and depression.
The primary measure of EDS was the Epworth Sleepiness Scale (M. W. Johns, 1992), an 8-
item measure. Each item is rated on a 4-point Likert scale ranging from never dozing (0) to
high chance of dozing (3) in specific soporific situations. Scores are summed, with higher
scores indicating greater sleepiness (M.W. Johns, 2000). A score >10 is usually considered
to indicate EDS. Previous research demonstrated a moderate level of discordance (40%)
between subjective and objective sleepiness with those who were discordant found to be
more likely to have only subjective sleepiness (Chugh, Weaver, & Dinges, 1996). To
capture the full number of subjects experiencing EDS the decision was made to use a self-
report measure of sleepiness as the primary outcome.
Items from the Kansas City Cardiomyopathy Questionnaire (KCCQ) (Green, Porter,
Bresnahan, & Spertus, 2000) were used as the measure of fatigue. Two items asking how
many times fatigue has limited the ability to do activities and how bothersome fatigue has
been were summed. Each item is scored 1 to 7. Scores ranging from 2 to 14 were reversed
so that higher scores indicated more fatigue. Although the median score was 5 in this
sample, a conservative score of 8 or more was used to indicate fatigue. The alpha coefficient
of the fatigue measure was 0.90 in this sample.
Sociodemographic characteristics were self-reported. Most clinical information (e.g.,
comorbid illnesses, HF type and duration, left ventricular ejection fraction) was gathered
from the medical record immediately prior to enrollment by a registered nurse. The total
number of comorbid conditions was used in analysis. Information on functional class was
gathered during the data collection visit by research assistants. Scoring of the New York
Heart Association (NYHA) is known to be subjective, so a standardized interview developed
for use in a NIH-funded trial was used to collect information on symptoms occurring in
response to activity (Kubo et al., 2004). The interview responses were provided to a single
board-certified cardiologist who scored NYHA in every subject. The score provided by the
cardiologist was used in analysis. Length of time with HF was calculated after a historical
search of the record to identify the initial physician diagnosis. BMI was calculated using
known height and body weight measured during the home visit. Research assistants recorded
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all current prescriptive and over-the-counter medications, including dose and frequency of
use.
A physician-judged diagnosis of SDB based on polysomnography was obtained from the
medical record at the time of enrollment. If no documentation of recent sleep testing was
found in the medical record, one night of sleep was assessed in the home using Embletta
(Medcare, Buffalo, NY), a highly sensitive and specific screening device useful in
quantifying the apnea hypopnea index (AHI) in persons with suspected SDB.(Ng et al.,
2010) An AHI ≥ 5 was used to classify subjects as having SDB (Ruehland et al., 2009).
Exercise frequency, alcohol use, and smoking history were self-reported. Exercise frequency
was gathered as categorical data in response to a question asking about the amount of
exercise obtained in the past week (none or fewer than 30 minutes, 30–59 minutes, 1–3
hours, or >3 hours). We asked about only the past week to avoid issues with recall related to
this type of behavior. To assess alcohol use participants were asked how often, on average,
they drink alcoholic beverages (never, 1 or fewer drinks/week, 2–7 drinks per week, 7 or
more per week, or 5 or more drinks on one occasion). Smoking history was categorized as
current smoker (smoking with 1 month of the encounter), recent smoker (stopped smoking
between 1 month and 1 year prior), former smoker (stopped more than one year ago), or
never smoked.
Sleep quality was assessed using the 19-item Pittsburgh Sleep Quality Index (PSQI), a self-
report measure of the perception of habitual sleep quality. Higher scores indicate worse
global sleep quality; a PSQI score greater than 5 indicates poor sleep quality (Buysse, 1989).
Perceived overall health was measured using a single item from the Medical Outcomes
Study (Ware, 1993). In general, would you say your health is poor, fair, good, very good, or
excellent?
Analysis
Standard descriptive statistics were used to depict the sample overall. Subjects were
categorized as having EDS or not. Then, Student’s t-tests were used to test for differences in
continuous variables and chi-square tests were used with categorical variables. The same
analyses were performed after categorizing subjects as fatigued or not. Simple linear
regression with backward elimination was used to evaluate the association between the
continuous Epworth Sleepiness Scale scores and the sociodemographic, clinical, behavioral,
and perceptual variables. The same procedures were used with the measure of fatigue.
Logistic regression was used to model the dichotomized EDS outcome, as well as the
dichotomized fatigued outcome. All analyses were adjusted for site, age, race and gender.
Analyses were conducted using SAS 9.2 (SAS Institute Inc., Cary, NC).
Results
Demographic and clinical characteristics of the sample of 280 are shown in Table 1. The
average subject tended to be a white (63%) male (64%) aged 62±12 years. The average
Epworth Sleepiness Scale total score was 6.95±4.56 (median = 6.0, mode 3.0) with a range
of 0 to 23 out of a possible score of 24. Many subjects were former smokers (55%) who
rated themselves to be in fair or poor health (54%). Almost all of these HF patients were
taking a beta-blocker (92%), 58% were taking an angiotensin-converting enzyme (ACE)
inhibitor, 30% were on an angiotensin II receptor blocker (ARB), and 81% were on a
diuretic. Of those on a diuretic, 84.5% were taking furosemide. Many subjects (n=132,
47.1%) had a recent polysomnography (PSG) and did not need further sleep testing.
Embletta was performed on 90 subjects (32.1%), but 4 studies were unsuccessful and 2
subjects removed the device during the night. In another 52 (18.6%) subjects, the presence
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or absence of SDB had been judged by a physician and noted in the medical record, but PSG
was not recent so we wanted to retest the patient. However, these 52 subjects either refused
the Embletta or delayed scheduling until it was too late to perform. In these patients, SDB
was judged based on the medical history in the record. A total of 151 (53.9%) subjects were
judged to have SDB based on the information in the medical record or Embletta testing. Of
these 151 patients with SDB, only 75 (49.7%) had been treated with CPAP and of these,
only 35 of the 151 (23.2%) reported using it ≥ 6 hours per night in the past week.
Characteristics of the sample separated by EDS and by fatigue are shown in Table 1.
Compared to subjects without EDS, subjects with EDS were younger (p=0.040), less likely
to have atrial fibrillation (p=0.033), less likely to be taking a diuretic (p=0.010), more likely
to be in NYHA functional class IV (p=0.002), and more likely to be classified as poor
sleepers on the PSQI (p=0.009). The prevalence of SDB did not differ between the groups
(Table 1).
Compared to subjects without fatigue, subjects with high levels of fatigue were younger (p<.
001) and more likely to be non-white race (p<0.001), to report an income that was
inadequate to meet their needs (p<0.001), and to perceive their health to be only fair or poor
(p<0.001). Fatigued subjects were more likely to be poor sleepers (p<.001), to have slept
less the night before data collection (p<.001), to be taking a higher number of prescription
drugs (p=.03) and more drugs causing daytime somnolence (p=.03) compared to subjects
who were not fatigued. Fatigued subjects were more likely to be in NYHA functional class
IV (p=0.001), more likely to be anemic (p=0.03), less likely to have atrial fibrillation
(p=0.01), and more likely to have diastolic HF (p=0.03) (Table 1).
Because sleep quality was anticipated to be a major contributor to both EDS and fatigue, we
tested bivariate associations between subjective sleep quality subscale scores, EDS, and
fatigue (Table 2). In unadjusted analyses, subjects with worse sleep quality, worse sleep
duration, more sleep disturbances, worse daytime dysfunction, or worse PSQI total sleep
quality scores tended to be more likely to have EDS and fatigue. The major sleep
disturbance was nocturia, reported by 74% of the sample.
Prevalence
Prevalence is defined as the proportion of individuals in a population having a particular
disease or diagnosis at a given time. In this case, the diagnosis of interest was EDS. Using a
score >10 on the Epworth Sleepiness Scale to define sleepiness, 23.6% of the participants
had EDS. Even more (28.2%) subjects were fatigued. The correlation between the Epworth
Sleepiness Scale and the fatigue score was r = .38 (p<.001).
Determinants of Excessive Daytime Sleepiness
Linear regression was used to evaluate the relative importance of the sociodemographic,
clinical, behavioral, and perceptual characteristics in predicting Epworth Sleepiness Scale
scores. The variables significantly associated with a higher score in the final adjusted model
were younger age (p=0.03), worse functional class (NYHA IV; p=.01), worse sleep quality
(p=0.01), fewer comorbid illnesses (p=0.03), and diuretic use (p=0.03). These variables
explained 21% of the variance in EDS.
The final adjusted models for the categorized EDS group are shown in Table 3. The odds of
having EDS increased by 9% for each unit increase in the total PSQI sleep score (p=0.048).
Those with NYHA functional class IV were more than four times as likely to have EDS
(p=0.004) compared to subjects in NYHA class I or II. Subjects taking a diuretic were 68%
less likely to have EDS (p=0.005). Those who were physically active between 1–3 hours
each week were 61% less likely to have EDS (p=0.04).
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Determinants of Fatigue—The final linear regression model developed for fatigue
scores found that the significant determinants of higher fatigue levels were worse sleep
quality score (p<.001) and worse NYHA functional class (p<.001). These variables
explained 31% of the variance in fatigue. For the logistic regression of fatigue, only sleep
quality was a significant determinant; fatigue increased by 24% for each unit of worsening
in the total PSQI sleep quality score (AOR=1.24, p<.001).
Discussion
The purpose of this study was to describe the prevalence of EDS and the factors associated it
in adults with HF. Although correlates of EDS have been tested in other populations, this is
the first study of this kind in adults with HF. Almost one quarter of our sample reported
EDS and even more reported fatigue. Interestingly, there was a moderately low correlation
between EDS and fatigue in this sample. Our EDS prevalence rate was lower than that found
in other HF studies. Redeker and Stein (2006) found EDS in 44% of their HF sample and
Staniforth et al (1998) identified EDS in 35% of their HF sample. EDS prevalence
differences may reflect medical management of the populations studied. We are unable to
make further comparisons between our study and these studies as Redeker and Stein did not
report the pharmacologic treatment of their sample. Staniforth et al reported on ACE
inhibitor and diuretic use, but beta-blockers were not in wide use at the time their study was
conducted.
The factors associated with EDS in these HF patients were poorer sleep quality, worse
functional class, lack of physical activity, and not taking a diuretic. These factors explained
more of the variance in fatigue than in EDS, although physical activity and diuretic use were
not significantly associated with fatigue. SDB was not associated with either EDS or fatigue
in this sample.
Poor sleep quality was a significant determinant of both EDS and fatigue, a finding similar
to that of prior investigators studying other patient groups (Kim & Young, 2005; Pack, et al.,
2006; Whitney, et al., 1998). The relationship between sleep quality and EDS and/or fatigue
may be explained by results from Redeker and Stein (2006) who reported that adults with
HF had more difficulty falling asleep, poor sleep efficiency, and more sleep disturbances,
early awakenings, and frequent napping than adults without HF.
Others have found a relationship between worse NYHA functional class and EDS in adults
with HF (Redeker & Stein, 2006; Staniforth, et al., 1998). A similar relationship was found
in the Cardiovascular Health Study (Whitney, et al., 1998) and in community-dwelling older
Americans enrolled in the National Sleep Foundation’s Sleep in America Poll (Chasens,
Sereika, Weaver, & Umlauf, 2007). One explanation for this finding is that subjects with
NYHA class IV HF have difficulty staying asleep in the supine position because of fluid
shifts from the peripheral to the central circulation (Yumino et al., 2010). It is also possible
that the direction of causation is reversed with EDS impairing functional abilities. The
direction of the effect cannot be determined from these cross-sectional data.
Subjects reporting engaging in physical activity between 1–3 hours each week experienced
significantly less EDS compared to those doing less activity. Others have previously noted a
relationship between physical activity and EDS (Chasens, et al., 2007; Whitney, et al.,
1998). Physical activity is thought to improve sleep quality (Driver & Taylor, 2000;
Youngstedt, 2005) and, in population studies, elders who are physically active report better
sleep than sedentary individuals (de Castro Toledo Guimaraes, de Carvalho, Yanaguibashi,
& do Prado, 2008; Paparrigopoulos, Tzavara, Theleritis, Soldatos, & Tountas, 2010;
Sherrill, Kotchou, & Quan, 1998). Studies testing the effects of various forms of physical
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activity on sleep parameters in older subjects have noted that sleep quality and duration are
improved in subjects who engage in endurance, weight, stretching, and/or balance training
(King, Oman, Brassington, Bliwise, & Haskell, 1997; King et al., 2008; Richards et al., in
press; Singh, Clements, & Fiatarone, 1997). Notably, however, these studies were not
performed in adults with HF.
Not taking a diuretic was associated with significantly more EDS in our sample. This was a
surprising finding, as diuretic use has been implicated as a factor interrupting sleep and
causing EDS (Asplund, 2004; Foley, et al., 2007). Reviewing the side effect profiles of the
major diuretic classes provided little insight into this finding but three possible scenarios
may explain the results. One plausible explanation is that subjects who were not taking a
diuretic were more likely to experience nocturnal dyspnea while in the supine position,
which would interrupt sleep. However, no interaction was found between NYHA functional
class and diuretic use. And, those taking a diuretic were no more likely to report sleep
disturbances than those not taking a diuretic (analysis not shown). Another possibility is that
not taking a diuretic is a surrogate marker of diastolic HF because some patients with
diastolic heart failure are sensitive to the preload reduction associated with diuretic use and
may develop hypotension or severe prerenal azotemia (Satpathy, Mishra, Satpathy,
Satpathy, & Barone, 2006). But, in this study diuretic use did not differ by HF type. The
most likely explanation for the association between a lack of diuretic use and EDS might be
linked to the reticular activating system (RAS), that area of the brainstem that regulates
wakefulness. Neurons in the RAS that play a role in wakefulness are dopaminergic,
noradrenergic, serotonergic, histaminic, and orexinic. The counterbalance to this arousal
system is the inhibitory influence of the GABAergic system, activation of which overrides
the wakefulness network and allows sleep (Jones & Jones, 2005). Sleep occurs when an area
of the anterior hypothalamus uses GABA and galanin to initiate sleep by inhibiting the
arousal regions of the brain (Foldvary-Schaefer et al., 2002). Prior investigators have
demonstrated that furosemide competitively blocks GABA from binding at the receptor sites
on the chloride inward channel, thus rendering them inadequately polarized to be effective
(Pond et al., 2006; Wall, 2003). Given this well established neurochemistry, it is plausible
that furosemide given during the day inhibits the GABAergic system, leaving the arousal/
wakefulness system relatively unopposed and inhibiting EDS.
We did not find EDS to be associated with SDB. SDB is exceedingly common in adults with
HF (MacDonald, Fang, Pittman, White, & Malhotra, 2008) and often assumed to be
associated with the high rates of EDS (Brostrom & Johansson, 2005; Redeker, 2006).
However, our results are consistent with those of recent studies of adults with HF in which
no association was found between SDB and EDS (Johansson et al., 2009; Redeker, Muench,
et al., 2010; Roure et al., 2008). The explanation for this lack of association remains unclear,
although Artz and colleagues (2006) note the HF patients appear to have a reduced
propensity to fall asleep, which may be explained by the increased sympathetic nervous
system activity in HF. The sympathetic stimulation is further accentuated by SDB. This
finding is important because it focuses our attention on issues such as functional class, sleep
quality, the medication regimen, and physical activity, which may be even more amenable to
treatment.
To our knowledge, this is the first study to simultaneously explore both EDS and fatigue in
the same sample. Several variables with univariate differences may help to explain the
differences between EDS and fatigue. Both those with EDS and with fatigue were
significantly younger than those without either symptom. Sensitivity of younger individuals
to symptoms could reflect age-related differences in interoception or the ability to receive
and process stimuli that originate inside the body (Cameron, 2001). Fatigued HF patients
were more likely to report an inadequate income and fair or poor health compared to patients
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without fatigue. This picture suggests that fatigue may reflect depression better than EDS.
However, fatigued HF patients were also more likely to be anemic and to be taking more
medicines—including those known to cause daytime somnolence—than patients who are
not fatigued. These characteristics suggest that patients who report fatigue should have their
medication regimen reevaluated and be checked for anemia.
A strength of this study is the relatively large sample size for a study of this nature. In
addition, the sample was older and more obese than prior studies of EDS, which makes these
results unique. Another strength was the inclusion of both EDS and fatigue. A limitation was
that a significant proportion of the sample refused Embletta testing so we had to depend on
historical data obtained from the medical record. Another limitation was the cross-sectional
nature of the data, which limits our ability to identify whether EDS is a cause or an effect.
Another limitation was the subjective nature of the symptom measures. However, symptoms
are defined as sensations or changes in bodily function experienced by a patient, so self-
report may be considered the gold standard for assessment. The sample itself was another
limitation; these subjects were fairly well-educated and overweight or obese. They were also
well-managed medically and had had HF longer than many published samples. Thus, these
results may not reflect the general population of HF patients elsewhere.
Application
In this sample, the major factors associated with EDS were poor sleep quality, worse NYHA
functional class, lack of physical activity, and not taking a diuretic. These results suggest
that medications that improve functional class, including diuretics, may decrease daytime
sleepiness in these patients. Sleep quality should be explored even in HF patients without
SDB; even mild decrements in sleep quality warrant concern and treatment.
These results are important because although SDB is widely studied in adults with HF, EDS
is not routinely addressed. Almost one-quarter of this sample experienced a high and
bothersome level of excessive daytime sleepiness, which illustrates the importance of
screening for this symptom in patients with HF. Patients with HF and risks for SDB should
be referred for testing, even if they do not have EDS.
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